|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/506 | (2006.01) |
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 1893213 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06760628.5 |
| Date of filing the European patent application | 2006-06-02 | |
| (97) | Date of publication of the European application | 2008-03-05 |
| (45) | Date of publication and mention of the grant of the patent | 2010-02-17 |
| (46) | Date of publication of the claims translation | 2010-04-21 |
| (86) | Number | PCT/US2006/021307 |
| Date | 2006-06-02 |
| (87) | Number | WO 2006/132930 |
| Date | 2006-12-14 |
| (30) | Number | Date | Country code |
| 687758 P | 2005-06-03 | US |
| (72) |
ALLAND, Leila, US
MANLEY, Paul, W., CH
MESTAN, Juergen, DE
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Pirimidilaminobenzamido junginių ir imatinibo derinys proliferacinių ligų gydymui arba prevencijai |
| COMBINATION OF PYRIMIDYLAMINOBENZAMIDE COMPOUNDS AND IMATINIB FOR TREATING OR PREVENTING PROLIFERATIVE DISEASES |
| Payment date | Validity (years) | Amount | |
| 2013-05-16 | 8 | 640.00 LTL |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2014-06-02 |